肾动脉直径与桥接支架长度对多分支腔内修复术后肾脏结局的影响
本研究基于两项前瞻性、非随机、医生发起的IDE研究(2017-2025年),纳入154例接受BEVAR并使用Viabahn支架的患者(250条肾动脉分支),评估肾动脉直径(≤5 vs >5 mm)和支架长度(<60 vs ≥60 mm)对肾脏结局的影响。
要点
- 大多数肾动脉靶血管不稳定(RA-TVI)事件发生在术后第一年(80%)。
核心结论
- BEVAR使用Viabahn支架后肾动脉分支闭塞发生率低(2.6%),但较小肾动脉和较长分支支架与更高的闭塞及不良肾脏结局风险相关。
研究设计与样本
- 研究为基于两项前瞻性、非随机、医生发起的IDE研究的回顾性分析,纳入2017-2025年接受BEVAR并使用Viabahn支架的连续患者,共154例患者、250条肾动脉分支。
主要发现
- 中位随访52个月,共4例(2.6%)患者发生4条肾动脉分支闭塞,1年和5年累积闭塞率分别为2±1.2%和2.8±1.4%。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Branched endovascular aortic repair (BEVAR) has been increasingly used as a treatment option for thoracoabdominal aortic aneurysms, but the risk of renal artery (RA) branch occlusion remains a concern. The aim of this study was to evaluate the effect of RA diameter and stent length on renal outcomes after BEVAR. METHODS: Clinical data from consecutive patients enrolled in two prospective, nonrandomized, physician-sponsored investigational device exemption studies between 2017 and 2025 were reviewed. Patients treated by BEVAR using patient-specific or off-the-shelf company-manufactured devices with at least one RA directional branch were included. All RA branches were treated with Viabahn (W. L. Gore & Associates, Inc) self-expandable and/or balloon-expandable stent grafts. RA diameter was stratified as ≤5 or >5 mm and branch stent length as <60 or ≥60 mm. The primary end point was the cumulative incidence of RA branch occlusion per patient. Secondary end points were RA branch primary patency, cumulative incidence of RA target vessel instability (RA-TVI; defined as any occlusion, stenosis requiring reintervention, or type Ic/IIIc endoleak), and cumulative incidence of acute kidney injury (AKI) and/or new-onset dialysis, as defined by Risk, Injury, Failure, Loss of kidney function, and End-stage kidney disease (RIFLE) criteria. RESULTS: A total of 154 patients (62% male, 71.7 ± 9.8 years old) underwent BEVAR with 250 RA directional branches. The diameter was ≤5 mm in 76 RA branches (30%) and >5 mm in 174 RA branches (70%), whereas RA branch stent length was <60 mm in 94 branches (38%) and ≥60 mm in 156 branches (62%). After a median follow-up of 52 months (75% interquartile range, 29-85 months), there were four (2.6%) patients with four RA branch occlusions. The cumulative incidence of RA branch occlusion per patient was 2 ± 1.2% and 2.8 ± 1.4% at 1 and 5 years, respectively. The incidence of RA branch occlusion was significantly higher in smaller RAs (≤5 mm: 9 ± 5% vs >5 mm: 1 ± 1%; P = .021) and longer RA branches (<60 mm: 2 ± 2.2% vs ≥60 mm: 3 ± 1.3%; P = .797) at 5 years. Similarly, RA primary patency was lower in smaller RAs (≤5 mm: 93 ± 3% vs >5 mm: 95 ± 3%; P = .093) and longer RA branches (<60 mm: 98 ± 1% vs ≥60 mm: 89 ± 5%; P = .097) during the same period. Most RA-TVI events (80%) occurred in the first year. At 5 years, the cumulative incidence of RA-TVI was similar by RA diameter (≤5 mm: 10 ± 3% vs 11 ± 3; P = .666) and RA branch stent length (<60 mm: 13 ± 5% vs ≥60 mm: 8 ± 3%; P = .574). AKI occurred in eight patients (5%), with only two patients (1%) requiring new-onset dialysis. There was no significant difference in the cumulative incidence of AKI or new-onset dialysis by RA diameter (<5 mm: 13.3 ± 8.7% vs ≥5 mm: 3.0 ± 2.1%; P = .06), but patients with longer RA branches had an increased risk at 5 years (<60 mm: 5.7 ± 1.1% vs ≥60 mm: 7.7 ± 0.8%; P = .042). CONCLUSIONS: The incidence of RA branch occlusion was low (2.6%) among patients treated with BEVAR using Viabahn self-expandable and/or balloon-expandable stent grafts, but the risk was higher among patients with smaller RAs and longer RA branches. Similarly, smaller RAs and longer RA branches had lower primary patency, with an increased cumulative incidence of RA-TVI for longer branches. Patients with longer RA branches had an increased incidence of AKI or new-onset dialysis at 5 years. These data provide a benchmark for comparison of custom BEVAR and T-branch devices with other multibranched thoracoabdominal aortic aneurysm stent graft designs.
引用
- Nunes VA, Theis C, Gomes VC, et al. Impact of renal artery diameter and bridging stent length on renal outcomes of patients treated by multibranch endovascular aortic repair. J Vasc Surg. 2026. PMID: 42235838. doi:10.1016/j.jvs.2026.05.035
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。